Effects of Renal Denervation on Sympathetic Activation, Blood Pressure, and Glucose Metabolism in Patients with Resistant Hypertension
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Increased central sympathetic drive is a hallmark of several important clinical conditions including essential hypertension, heart failure, chronic kidney disease, and insulin resistance. Afferent signaling from the kidneys has been identified as an important contributor to elevated central sympathetic drive and increased sympathetic outflow to the kidney and other organs is crucially involved in cardiovascular control. While the resultant effects on renal hemodynamic parameters, sodium and water retention, and renin release are particularly relevant for both acute and long term regulation of blood pressure, increased sympathetic outflow to other vascular beds may facilitate further adverse consequences of sustained sympathetic activation such as insulin resistance, which is commonly associated with hypertension. Recent clinical studies using catheter-based radiofrequency ablation technology to achieve functional renal denervation in patients with resistant hypertension have identified the renal nerves as therapeutic target and have helped to further expose the sympathetic link between hypertension and insulin resistance. Initial data from two clinical trials and several smaller mechanistic clinical studies indicate that this novel approach may indeed provide a safe and effective treatment alternative for resistant hypertension and some of its adverse consequences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension
Peppard, P. E., Young, T., Palta, M., & Skatrud, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421901 · Cited by 4,973 · cited 1×
“…activity in various forms of hypertension including essential hypertension (Esler, 2000), obesity related hypertension (Esler et al., 2006), renal hypertension (Schlaich, 2011), hypertension associated with obstructive sleep apnea (Peppard et al., 2000), and preeclampsia (Schobel et al., 1996).”
BackgroundKrum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60566-3 · Cited by 2,108
Self-citationNeural control of renal function
DiBona, G. F., & Kopp, U. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.1.75 · Cited by 1,212
Neural Control of Renal Function*
Kopp, U. C., & DiBona, G. F. (2020) · Reflex Control of the Circulation · doi:10.1201/9780367813338-17 · Cited by 1,126
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930
Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension
Schlaich, M. P., Sobotka, P. A., Krum, H., Lambert, E., & Esler, M. D. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0904179 · Cited by 772 · cited 12×
“…models of various conditions characterized by heightened sympathetic drive and consistently demonstrated the importance of renal efferent and afferent nerves and their contribution to the pathophysiology of hypertension, heart failure, and chronic kidney disease (Schlaich et al., 2009b).”
BackgroundInfluentialSelf-citationAdverse consequences of high sympathetic nervous activity in the failing human heart
Kaye, D. M., Lefkovits, J., Jennings, G. L., Bergin, P., Broughton, A., & Esler, M. D. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00332-0 · Cited by 665 · cited 2×
“…is even more pronounced in heart failure (Kaye et al., 1994), a common clinical consequence of long term and sustained elevated BP. Renal sympathetic activation has been shown to predict all-cause mortality and heart transplantation in patients with congestive heart failure (Kaye et al., 1995).”
BackgroundSelf-citationZoccali, C., Mallamaci, F., Parlongo, S., Cutrupi, S., Benedetto, F. A., Tripepi, G., Bonanno, G., Rapisarda, F., Fatuzzo, P., Seminara, G., et al. (2002) · Circulation · doi:10.1161/hc1102.105261 · Cited by 519 · cited 2×
“Similarly, elevated norepinephrine plasma levels have been identified as major contributors to adverse CV outcomes in end-stage renal disease (Zoccali et al., 2002), another condition commonly characterized by substantially elevated sympathetic nerve activity (Schlaich et al., 2009a).”
BackgroundThe sympathetic system and hypertension*1
ESLER, M. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)00225-9 · Cited by 479
Self-citationRelation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy
Schlaich, M. P., Kaye, D. M., Lambert, E., Sommerville, M., Socratous, F., & Esler, M. D. (2003) · Circulation · doi:10.1161/01.cir.0000081775.72651.b6 · Cited by 459 · cited 2×
“…plasma clearly demonstrated that renal norepinephrine spillover rates are markedly elevated in patients with essential hypertension (Schlaich et al., 2004) and are associated with hypertensive target organ damage such as left ventricular (LV) hypertrophy (Schlaich et al., 2003; Burns et al., 2007).”
BackgroundMethodSelf-citationMechanisms of Sympathetic Activation in Obesity-Related Hypertension
Esler, M., Straznicky, N., Eikelis, N., Masuo, K., Lambert, G., & Lambert, E. (2006) · Hypertension · doi:10.1161/01.hyp.0000242642.42177.49 · Cited by 443
Self-citationSympathetic Activation in Chronic Renal Failure
Schlaich, M. P., Socratous, F., Hennebry, S., Eikelis, N., Lambert, E. A., Straznicky, N., Esler, M. D., & Lambert, G. W. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008040402 · Cited by 408 · cited 3×
“…of Greifswald, Germany *Correspondence: Markus P. Schlaich, Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, VIC 8008, Australia. e-mail: markus.schlaich@ bakeridi.edu.au Increased central…”
BackgroundSelf-citationReflex sympathetic activation induces acute insulin resistance in the human forearm.
Jamerson, K. A., Julius, S., Gudbrandsson, T., Andersson, O., & Brant, D. O. (1993) · Hypertension · doi:10.1161/01.hyp.21.5.618 · Cited by 311
Early Sympathetic Activation in the Initial Clinical Stages of Chronic Renal Failure
Grassi, G., Quarti-Trevano, F., Seravalle, G., Arenare, F., Volpe, M., Furiani, S., Dell'Oro, R., & Mancia, G. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.164780 · Cited by 311
Burns, J., Sivananthan, M. U., Ball, S. G., Mackintosh, A. F., Mary, D. A. S. G., & Greenwood, J. P. (2007) · Circulation · doi:10.1161/circulationaha.106.668863 · Cited by 122 · cited 1×
“…plasma clearly demonstrated that renal norepinephrine spillover rates are markedly elevated in patients with essential hypertension (Schlaich et al., 2004) and are associated with hypertensive target organ damage such as left ventricular (LV) hypertrophy (Schlaich et al., 2003; Burns et al., 2007).”
Background
Cited by
Krum, H., Schlaich, M. P., Sobotka, P. A., Böhm, M., Mahfoud, F., Rocha-Singh, K., Katholi, R., & Esler, M. D. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62192-3 · Cited by 619
Self-citationBacterial-mediated drought tolerance: Current and future prospects
Ngumbi, E., & Kloepper, J. (2016) · Applied Soil Ecology · doi:10.1016/j.apsoil.2016.04.009 · Cited by 491
Anatomic Assessment of Sympathetic Peri-Arterial Renal Nerves in Man
Sakakura, K., Ladich, E., Cheng, Q., Otsuka, F., Yahagi, K., Fowler, D. R., Kolodgie, F. D., Virmani, R., & Joner, M. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.059 · Cited by 406
“Our results suggest that the nonselective partial renal denervation of both efferent and afferent nerve fibers is likely to play a causative role for the effective treatment of resistant hypertension, which has been achieved in the Symplicity HTN-1 and -2 and the EnligHTN I trials (2,11) and other non–BP-related effec…”
BackgroundRole of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2
Matthews, V. B., Elliot, R. H., Rudnicka, C., Hricova, J., Herat, L., & Schlaich, M. P. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001434 · Cited by 222
Self-citationRenal Sympathetic Denervation in Patients With Heart Failure With Preserved Ejection Fraction
Kresoja, K.-P., Rommel, K.-P., Fengler, K., von Roeder, M., Besler, C., Lücke, C., Gutberlet, M., Desch, S., Thiele, H., Böhm, M., et al. (2021) · Circulation: Heart Failure · doi:10.1161/circheartfailure.120.007421 · Cited by 96
Metadata
- Authors
- Schlaich, M. P., Hering, D., Sobotka, P., Krum, H., Lambert, G. W., Lambert, E., & Esler, M. D.
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 3
- Pages
- 10-10
- ISSN
- 1664-042X (ISSN-L)
- OpenAlex
- W2141671359
- Cited by
- 80
- References
- 15
- FWCI
- 8.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.